ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin (Q31005436)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

9 October 2017

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin (English)

1 reference

Europe PubMed Central

9 October 2017

1 reference

based on heuristic

inferred from title

small cell carcinoma

1 reference

based on heuristic

inferred from title

supporting evidence

1 reference

based on heuristic

inferred from title

Sean R. Williamson

1

1 reference

Europe PubMed Central

9 October 2017

Rodolfo Montironi

9

object named as

Rodolfo Montironi

1 reference

Europe PubMed Central

9 October 2017

4

object named as

Jiaoti Huang

1 reference

Europe PubMed Central

9 October 2017

10

object named as

Liang Cheng

1 reference

Europe PubMed Central

9 October 2017

Antonio Lopez-Beltran

5

object named as

Antonio Lopez-Beltran

1 reference

Europe PubMed Central

9 October 2017

author name string

Shaobo Zhang

2

1 reference

Europe PubMed Central

9 October 2017

Jorge L Yao

3

1 reference

Europe PubMed Central

9 October 2017

Steven Shen

6

1 reference

Europe PubMed Central

9 October 2017

Adeboye O Osunkoya

7

1 reference

Europe PubMed Central

9 October 2017

Gregory T MacLennan

8

1 reference

Europe PubMed Central

9 October 2017

publication date

15 April 2011

1 reference

Europe PubMed Central

9 October 2017

Modern Pathology

1 reference

Europe PubMed Central

9 October 2017

24

1 reference

Europe PubMed Central

9 October 2017

8

1 reference

Europe PubMed Central

9 October 2017

1120-1127

1 reference

Europe PubMed Central

9 October 2017

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Unusual and underappreciated: small cell carcinoma of the prostate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Small cell carcinoma of the prostate: an immunohistochemical study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Neuroendocrine differentiation in prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Chemotherapy for Small Cell Carcinoma of Prostatic Origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3441178

21 June 2018

Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

Complex patterns of ETS gene alteration arise during cancer development in the human prostate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

ERG rearrangement in small cell prostatic and lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

Detection of TMPRSS2 gene deletions and translocations in carcinoma, intraepithelial neoplasia, and normal epithelium of the prostate by direct fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

ERG rearrangement is present in a subset of transition zone prostatic tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications—A Retrospective Study of 30 Patients From the Rare Cancer Network

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.56

21 January 2018

The histogenesis of small cell carcinoma of the prostate an immunohistochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcomes of small cell carcinoma of the prostate: a single-center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21499238

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/MODPATHOL.2011.56

1 reference

Europe PubMed Central

9 October 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 October 2017

1 reference

Europe PubMed Central

9 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31005436&oldid=2175432037"